The potential for mathematical modelling in the assessment of the radiation dose equivalent of cytotoxic chemotherapy given concomitantly with radiotherapy

British Journal of Radiology

Volumn 78, Issue 934, 2005, Pages 939-943

  Jones, B ^a   Dale, R G ^b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYTOTOXIC AGENT;

ARTICLE; BIOEQUIVALENCE; CANCER CELL DESTRUCTION; CANCER INHIBITION; CANCER REGRESSION; MALIGNANT NEOPLASTIC DISEASE; MATHEMATICAL MODEL; MEDICAL DECISION MAKING; MULTIMODALITY CANCER THERAPY; POISSON DISTRIBUTION; PROBABILITY; RADIATION DOSE; RADIOBIOLOGY; RADIOLOGICAL PARAMETERS; RADIOSENSITIZATION;

ANTINEOPLASTIC AGENTS; CELL DEATH; COMBINED MODALITY THERAPY; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; POISSON DISTRIBUTION; RADIOTHERAPY; RADIOTHERAPY DOSAGE; THERAPEUTIC EQUIVALENCY; TREATMENT OUTCOME;

EID: 27744569421     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/40226390     Document Type: Article

References (21)

1. Munro AJ. An overview of randomised control trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 1995;71:83-91.
2. Henk JM. Concomitant chemoradiation for head and neck cancer: saving lives or saving grays? Clin Oncol 2001;13:333-5.
3. Rosenthal DI, Ang KK. Altered radiation therapy fractionation, chemoradiation and patient selection for the treatment of head and neck squamous cell carcinoma. Semin Radiat Oncol 2004;14:153-66.
4. Tobias JS, Ball D. Synchronous chemoradiation for squamous carcinomas. BMJ 2001;322:876-8.
5. Rose PG, Eifel PJ. Combined radiation therapy and chemotherapy for carcinoma of the cervix. Cancer J 2001;7:86-94.
6. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001;358:781-6.
7. Britten RA, Peacock J, Warenius HIM. Collateral resistance to photon and neutron irradiation is associated with acquired cis-platinum resistance in human ovarian tumour cells. Radiother Oncol 1992;23:170-5.
8. Dale RG. The application of the linear quadratic theory to fractionated and protracted radiotherapy. Br J Radiol 1985;58:515-28.
9. Fowler JF. The linear quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989;62:679-94.
10. Jones B, Dale RG, Deehen C, Hopkins KI, Morgan DAL. The role of biological effective dose (BED) in clinical oncology. Clin Oncol 2001;13:71-81.
11. Dale RG. Time-dependent tumour repopulation factors in the linear quadratic equations - implications for treatment strategies. Radiother Oncol 1989;15:371-82.
12. Fowler JF. Biological factors influencing optimal fractionation in radiation therapy. Acta Oncologica 2001;40:712-7.
13. Fowler JF, Harari PM. Confirmation of improved local-regional control with altered fractionation in head and neck cancer. Int J Radiat Oncol Biol Phys 2000;48:3-6.
14. Jones B, Dale RG. Inclusion of molecular biotherapies with radical radiotherapy: modelling of combined modality treatment schedules. Int J Radiat Oncol Biol Phys 1999;45:1025-34.
15. Jones B, Cominos M, Dale RG. Application of biological effective dose (BED) to estimate the duration of symptomatic relief and repopulation dose equivalent in palliative radiotherapy and chemotherapy. Int J Radiat Oncol Biol Phys 2003;55:736-42.
16. Porter EH. The statistics of dose/cure relationships for irradiated tumours. Br J Radiol 1980;53:210-27.
17. Webb S, Nahum AE. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol 1993;38:653-66.
18. Niemierko A, Goitein M. Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor. Radiother Oncol 1993;29:140-7.
19. Jones B, Dale RG. The reduction in tumour control with increasing overall time: mathematical considerations. Br J Radiol 1996;69:830-8.
20. Jones B, Dale RG. Mathematical models of tumour and normal tissue response. Acta Oncol 1999;38:883-93.
21. Jones B, Dale RG. Radiobiological modelling and clinical trials. Int J Radiat Oncol Biol Phys 2000;48:259-65.